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Abstract
Prion diseases are invariably fatal neurodegenerative diseases that affect humans and
animals. Unlike most other amyloid forming neurodegenerative diseases, these can
be highly infectious. Prion diseases occur in a variety of species. They include the
fatal human neurodegenerative diseases Creutzfeldt-Jakob Disease (CJD), Fatal Famil-
ial Insomnia (FFI), Gerstmann-Strussler-Scheinker syndrome (GSS), Kuru, the bovine
spongiform encephalopathy (BSE or ‘mad-cow’ disease) in cattle, the chronic wasting
disease (CWD) in deer and elk, and scrapie in sheep and goats, etc. Transmission across
the species barrier to humans, especially in the case of BSE in Europe, CWD in North
America, and variant CJDs (vCJDs) in young people of UK, is a major public health
concern. Fortunately, scientists reported that the hydrophobic region of prion proteins
(PrP) controls the formation of diseased prions. This article gives a detailed survey on
PrP hydrophobic region and does molecular dynamics studies of human PrP(110–136)
to confirm some findings from the survey.
Keywords: prion diseases; prion protein; central hydrophobic region; a detailed
survey; molecular dynamics study
1. Introduction
“Mad cow disease” (i.e. Bovine Spongiform Encephalopathy (BSE)) belongs to
a contagious type of Transmissible Spongiform Encephalopathies (TSEs). Scientists
believe it is caused by Prions (the misfolding prion proteins) but they may have not
yet solved the riddle of “mad cow disease”. This is due to a prion is neither a virus,
a bacteria nor any microorganism so the disease cannot be caused by the vigilance
of the organism immune system and it can freely spread from one species to another
species. The humans exists the susceptibility of TSEs; for example, the human version
of mad cow disease named Creutzfeldt-Jakob Disease (CJD) and variant CJD (vCJD)
just happen randomly through infections of transplanted tissue or blood transfusions
or consumption of infected beef products. Cat, mink, deer, elk, moose, sheep, goat,
nyala, oryx, greater kudu, ostrich and many other species are also susceptible to TSEs.
Scientists do not know the reason of TSEs.
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Fortunately, scientists reported that the hydrophobic region 109–136 of prion pro-
teins (PrP) controls the formation of diseased prions. This article firstly gives a detailed
survey on PrP hydrophobic region; secondly, this article does molecular dynamics
(MD) studies of human PrP(110–136) (PDB ID: 2LBG.pdb) to confirm some find-
ings from the survey and to try to reveal something new.
It was reported that the hydrophobic region PrP(109–136) controls the formation of
diseased prions: the normal PrP(113–120) AGAAAAGA palindrome is an inhibitor/blocker
of prion diseases [Brown (2000); Holscher et al. (1998)] and the highly conserved
glycine-xxx-glycine motif PrP(119–131) can inhibit the formation of infectious prion
proteins in cells [Harrison et al. (2010); Cheng et al. (2011); Lee et al. (2008)]. The
first part of this article will review the research works on all the PrP hydrophobic re-
gions.
The infectious diseased prion is thought to be an abnormally folded isoform (PrPSc)
of a host protein known as the prion protein (PrPC). The conversion of PrPC to PrPSc
occurs post-translationally and involves conformational change from a predominantly
α-helical protein to one rich in β-sheet amyloid fibrils. Much remains to be understood
about how the normal cellular isoform of the prion protein PrPC undergoes structural
changes to become the disease associated amyloid fibril form PrPSc. Such a structural
conformational change may be amenable to study by MD techniques. The second part
of this article will do MD studies on the hydrophobic region 110–136 of human PrP
(HuPrP).
The rest of this paper is organized as follows. Firstly, we will review previous ex-
perimental research results in the laboratories (not on the computers) on the hydropho-
bic region of PrP listed in the PubMed of NCBI (http://www.ncbi.nlm.nih.gov/pubmed).
Secondly, we will present MD simulation studies on HuPrP(110–136). Lastly, conclud-
ing remarks on PrP hydrophobic region are summarized.
2. A detailed review on PrP hydrophobic region
The highly and evolutionarily conserved PrP hydrophobic region has been consid-
ered essential to PrP conformational conversion. This section does a survey of the
research work on prion hydrophobic region listed in the PubMed database mainly from
the molecular structure point of view.
• 2014:
– Chu et al. (2014) equipped ∆105-125, ∆CR PrP (i.e. the PrP missing
central hydrophobic region, a variant that is known to be highly neurotoxic
in transgenic mice) with a C-terminal membrane anchor via a semisynthesis
strategy and found the importance of the central hydrophobic domain in the
membrane anchor in PrP-lipid interactions [Chu et al. (2014)].
– Daskalov et al. (2014) studied the HET-s prion (which owns a β-solenoid
with a triangular hydrophobic core) and identified a region that modulates
prion formation [Daskalov et al. (2014); Saupe (2011)]. Solid-state NMR
data showed the hydrophobic core of HET-s(218–289) is rigid [Lange et al.
(2009)].
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– Xu et al. (2014) presented the structures of prion-like MAVS and found
there are “electrostatic interactions between neighboring strands and hy-
drophobic interactions within each strand” [Xu et al. (2014)].
– Baral et al. (2014) did promazine binding to mouse PrP and found the
“binding induces structural rearrangement of the unstructured region prox-
imal to β1, through the formation of a ‘hydrophobic anchor’” and pro-
mazine ”stabilizes the misfolding initiator-motifs such as the C terminus of
α2, the α2-α3 loop, as well as the polymorphic β2-α2 loop” [Baral et al.
(2014)].
– Coleman et al. (2014) studied the murine homologues (G113V and A116V,
which lie in the hydrophobic domain of PrP) and concluded that “the hy-
drophobic domain is an important determinant of PrP conversion” [Coleman et al.
(2014); Zhang (2014a)].
– Mays et al. (2014) studied the C1 cleavage that occurs amino-terminal of
PrPC’s hydrophobic domain [Mays et al. (2014)].
• 2013:
– Wang et al. (2013) used [Au(bpy)Cl2]PF6 and [Au(dien)Cl]Cl2 (where bpy
is 2,2’-bipyridine and dien is diethylenetriamine), six prion peptides with
either a His111-mutated or a Met109/112-mutated residue to investigate
interaction and peptide aggregation [Wang et al. (2013)].
– Pimenta et al. (2013) described the NMR structure of ovine prion-like
Doppel peptide (1–30) (PDB ID: 2M1J) and the interaction of this peptide
with the conserved SRP54M hydrophobic groove [Pimenta et al. (2013)].
– The central domain (CD, 95-133) of PrPC comprises the charge cluster
(CC, 95-110) and a hydrophobic region (HR, 112-133); Vilches et al. (2013)
reported that among CC, HR and CD only the CD peptide is neurotoxic and
this peptide is able to activate caspase-3 and disrupt the cell membrane,
leading to cell death [Vilches et al. (2013)].
– “Among mutants spanning the region 95-135, a construct lacking solely
residues 105-125 (△105–125) had distinct properties when compared with
the full-length prion protein 23-231 or other deletions” [Patel et al. (2013)].
– Zweckstetter (2013) reported that “prion stop mutants that accumulate in
amyloidogenic plaque-forming aggregates fold into a β-helix” and residue
129 is located in the hydrophobic core of the β-helix, the trimer interface
of a trimeric left-handed β-helix model is formed by residues L125, Y128
and L130 [Zweckstetter (2013)].
• 2012:
– Lau et al. (2012) demonstrated that Shadoo (Sho) binds DNA and RNA
in vitro via the arginine-rich (or alanine-rich) hydrophobic region of five
tandem A/LAAG amino residue repeats R1-R5 (including tandem posi-
tively charged “RGG boxes”), where is the most homologous region of Sho
and PrP (but Sho sequences showed variability in the number of alanine
residues) [Lau et al. (2012); Daude et al. (2010); Stewart et al. (2009)].
– Zhao et al. (2012) reported that “two fixed missense mutations (102Ser→Gly
and 119Thr→Ala), and three missense mutations (92Pro>Thr/Met, 122Thr>Ile
3
and 139Arg>Trp) in the coding region presenting different (P<0.05) geno-
typic and allelic frequency distributions between cattle and buffalo” [Zhao et al.
(2012)].
– 14–3–3 beta protein (highly abundant in brain, a biomarker for sCJD) in-
teracts with the central hydrophobic amino acids 106-126 of prion protein
[Jeong et al. (2012)].
– The α-cleavage within the central hydrophobic domain not only disrupts a
region critical for both PrP toxicity and PrPC to PrPSc conversion but also
produces the N1 fragment that is neuroprotective and the C1 fragment that
enhances the proapoptotic effect of staurosporine in one report and inhibits
prion in another [Liang et al. (2012)].
– Zhang et al. (2012) found a new haplotype in a Sunite sheep and the sheep
of Inner Mongolia in China have several haplotypes with the similar results
of Stewart and Daude’s: SPRN (shadowof prion protein homology) con-
tained an alanine-rich sequence, which is homologous to a hydrophobic
core with amyloidgenic characteristics in PrP [Zhang et al. (2012)].
– Sauve et al. (2012) published the NMR structure of HuPrP(110–136) in do-
decylphosphocholine (DPC) micelles (PDB ID: 2LBG) [Sauve et al. (2012)].
• 2011:
– Biljan et al. (2011) published the NMR structure of HuPrP-M129 mutant
V210I (85–231) (PDB ID: 2LEJ) including the unstructured N-terminal
part (residues 90-124) [Biljan et al. (2011)].
– Julien et al. (2011) reported the relative and regional stabilities of the ham-
ster, mouse, rabbit, and bovine PrPs towards urea unfolding, and also in-
vestigated the effect of the S174N mutation in rabbit PrPC [Julien et al.
(2011)].
– Shi et al. (2011) reported that point-mutations within the hydrophobic
transmembrane region increase the amount of CtmPrP (a kind of PrPSc) in
cells, such as human homologue A117V which is associated with GSS and
G114V associated with gCJD, while the mutations outsides transmembrane
region do not [Shi et al. (2011)].
• 2010:
– Wang et al. (2010) reported that “the hydrophobic domain deletion mutant
significantly weakened the hydrophobic rPrP-lipid interaction and abol-
ished the lipid-induced C-terminal PK-resistance”, “both disease-associated
P105L and P102L mutations, localized between lysine residues in the pos-
itively charged region, significantly affected lipid-induced rPrP conver-
sion” and “the hydrophobic domain localized 129 polymorphism altered
the strength of hydrophobic rPrP(recombinant mouse PrP)-lipid interac-
tion” [Wang et al. (2010)].
– Ile et al. (2010) published the NMR structure of HuPrP-M129 mutant
Q212P (PrP(90–231)) (PDB ID: 2KUN) and concluded that the Q212P
mutation caused GSS syndrome might be due to the disruptions of the hy-
drophobic core consisting of β2-α2 loop and α3 helix [Ile et al. (2010)].
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– Biasini et al. (2010) revealed through the deleting residues 114-121 (△114–
121) that the hydrophobic core region governs mutant prion protein aggre-
gation and intracellular retention [Biasini et al. (2010)].
– Harrison et al. (2010) reported that there are similarities between Aβ
(Alzheimer’s amyloid-β) and PrP in the segment of the three GxxxG re-
peats (where both Aβ and PrP have the crucial residue Methionine located
in the middle (GxMxG) of the last repeat) that controls prion formation,
and found that minor alterations to this highly conserved region of PrPC
drastically affect the ability of cells to uptake and replicate prion infection
in both cell and animal bioassay [Harrison et al. (2010); Zhang (2014a)].
– Oliveira-Martins et al. (2010) reported that “PrPC undergoes extensive pro-
teolysis at the α site (109K↓H110)” and “C1 prevalence was unaffected by
variations in charge (PrP(90–110)) and hydrophobicity (PrP(110–130)) of
the region neighbouring the α-cleavage site, and by substitutions of the
residues in the palindrome that flanks this site, instead, α-cleavage was
size-dependently impaired by deletions within the domain PrP(106-119)”
[Oliveira-Martins et al. (2010)].
– The hydrophobic core (HC), a transmembrane domain, harbors the most
highly conserved regions of PrPC. A mutation in HC is associated with
prion disease resulting in an enhanced formation of a transmembrane form
(CtmPrP). Lutz et al. (2010) created a set of mutants carrying microdele-
tions of 28 amino acids within HC between position 114 and 121 (△114–
121), and showed that these mutations display reduced propensity for trans-
membrane topology and HC might function as recognition site for the
protease(s) responsible for PrPC α-cleavage[Lutz et al. (2010)]. They also
found that the mutant G113V displayed increased CtmPrP topology and de-
creased α-cleavage in their in vitro assay and concluded that HC represents
an essential determinant for transmembrane PrP topology, whereas the high
evolutionary conservation of this region is rather based upon preservation
of PrPC α-cleavage, thus highlighting the biological importance of this
cleavage.
– Valensin et al. (2010) reported that HuPrP possesses two copper binding
sites localized at His-96 and His-111 in the so called “amylodogenic” or
neurotoxic region (residues 91-126) and chicken PrP possesses a similar
region (PrP(105–140)) containing two His (His-110 and His-124) and an
identical hydrophobic tail of 15 amino acids rich in Ala and Gly [Valensin et al.
(2010)].
– Turi et al. (2010) studied HuPrP(91–115), HuPrP(76–114)H85Aand HuPrP(84–
114)H96A and found that His96 predominates almost completely for nickel(II)
ions, while His85 and His111 predominate copper(II) ions [Turi et al. (2010);
Joszai et al. (2012); Cui et al. (2014)].
• 2009:
– Julien et al. (2009) reported that “strong hydrophobic interactions between
helices α1 and α3, and between α2 and α3, stabilize these regions even at
very high concentrations of urea” but this result is for PrP structural region
121–230 of bovine [Julien et al. (2009)].
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– Fei et al. (2009) reported Preceding with a hydrophobic residue cysteine,
instead of a charged residue, “caused the rate of assembly into fibrils to in-
crease greatly for both peptides and full-length Ure2p”, and concluded that
“disulfide bond formation significantly accelerates the assembly of Ure2p
fibrils because of the proximity of a potential amyloid stretch” [Fei et al.
(2009)].
– Tseng et al. (2009) reported that hydrophobic does not play a major role in
the unfolding of α-helix 1 of PrPC [Tseng et al. (2009)] but In the mouse
PrP (PDB ID: 1AG2) there are nine hydrophobic residues and five non-
polar Glycines in β1-strand: GLGGYMLGSAMSRPMIHFGN(PrP(124–
142)), five hydrophobic residues in β2-strand: N153MYRYPNQV YYR-
PVD167 (PrP(153–167)).
• 2008:
– Margittai et al.(2008) found that, to maximize the hydrophobic contact
surface, most fibrils (that contain an extensive core region of about 20
amino acids or more) share a common parallel in-register arrangement of
β-strands [Margittai et al. (2008)].
– Ciccotosto et al. (2008) reported “the major region of neurotoxicity has
been localized to the hydrophobic domain located in the middle of the PrP
sequence” [Ciccotosto et al. (2008)].
• 2007:
– Owen et al. (2007) reported “the protease thermolysin cleaves at the hy-
drophobic residues Leu, Ile, Phe, Val, Ala, and Met, residues that are absent
from the protease accessible aminoterminal region of PrPSc” [Owen et al.
(2007)].
– Ott et al. (2007) reported “the presence of small hydrophobic amino acids
such as Val and Ile was insufficient to promote re-orientation. Only Met
and Leu, large hydrophobic amino acids, could promote transmembrane
domain inversion” [Ott et al. (2007)].
– Sakudo et al. (2007) reported that neurotoxic signals of aged PrP(106–126)
are mediated by N-terminal half of the hydrophobic region (HR) but not the
octapeptide repeat (OR) of PrP [Sakudo et al. (2007)].
– Berti et al. (2007) reported the copper(II) binding result of the 91–120
region of HuPrP: “room-temperature NMR spectroscopy data were consis-
tent with the binding site centered on His111 being approximately fourfold
stronger than that centered on His96, low-temperature EPR spectroscopy
results yielded evidence for the opposite trend”, and the MD results showed
that “Met112 approaching the metal at room temperature, a process that is
expected to stabilize the His111-centered binding site through hydrophobic
shielding of the metal coordination sphere” [Berti et al. (2007)].
– Harrison et al. (2007) summarized the GxxxG PrPctm motif GAVVG-
GLGGYMLG and made a mutation G131V leading to the possibility that
this motif may be relevant to the actions of TM-PrP [Harrison et al. (2007)].
• 2006:
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– Lee et al. (2006) found that “the OR (octapeptide repeat region, PrP(51–
90)) and N-terminal half of HR (hydrophobic region, PrP(112–145)) of PrP
retains anti-apoptotic activity similar to full-length PrP” [Lee et al. (2006)].
• 2005:
– Sakudo et al. (2005a) reported that “OR and N-terminal half of the HR
were required for the inhibitory effect of PrP(113-132) but not STI1 (stress-
inducible protein 1) pep.1” and “mediate the the action of STI1 upon cell
survival and upregulation of SOD (superoxide dismutase) activity” [Sakudo et al.
(2005a)]. In 2005, Sakudo et al. (2005b) also reported that “Removal of the
OR (PrP(53–94)) enhances apoptosis and decreases SOD activity. Deletion
of the N-terminal half of HR (PrP(95–132)) abolishes its ability to acti-
vate SOD and to prevent apoptosis, whereas that of the C-terminal half of
HR (PrP(124-146)) has little if any effect on the anti-apoptotic activity and
SOD activation” [Sakudo et al. (2005b)].
– Gaggelli et al. (2005) did NMR and EPR studies on the interaction of the
HuPrP(106–126) (KTNMKHMAGAAAAGAVVGGLG) with copper(II),
manganese(II) and zinc(II) at pH 5.7 and concluded that “the hydrophobic
C-terminal region was not affecting the copper-binding (of His111) prop-
erties of the peptide and this hydrophobic tail is left free to interact with
other target molecules” [Gaggelli et al. (2005)].
• 2004:
– Kuznetsov et al. (2004) reported that “PrP(114-125) and the C terminus
of helix B may be considered as primary candidates for sites involved in
conformational transition from PrPC to PrPSc” and “most PrP mutations
associated with neurodegenerativedisorders increase local hydrophobicity”
[Kuznetsov et al. (2004)].
– Ott et al. (2004) reported that “the N terminal and hydrophobic regions of
the signal sequence affect (membrane) integration (of priton protein) most
significantly. Mutations in either region result in a considerable increase in
the number of chains that integrate” [Ott et al. (2004)].
– Haire et al. (2004) reported that the strand of residues 129-131 in sheep
PrP crystal structure is involved in lattice contacts about a crystal dyad
to generate a four-stranded intermolecular β-sheet between neighbouring
molecules [Haire et al. (2004)].
• 2003:
– Susceptibility to scrapie is primarily controlled by polymorphisms in the
ovine PrP gene (PRNP) and Seabury et al. (2003) reported a polymorphism
of ovine PrP at Proline 116, flanking the cleavage site between Lys112 and
His113, and A117V (causing Gerstmann-Strausler-Scheinker syndrome)
[Seabury et al. (2003)].
– Saez-Cirion et al. (2003) reported that the hydrophobic internal region
130GAVVGGLGGYMLGSAMSR147 of bovine PrP shares structural and
functional properties with HIV type 1 fusion peptide [Saez-Cirion et al.
(2003)]. The 121KHVAGAAAAGAVVGGLGGYMLGSAMSR147 trans-
membrane region (BovinePrP(tm)) has mainly a helical structure but also
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containing some random coil (upon addition of calcium, the random coils
disappear while the helical conformation remains) [Saez-Cirion et al. (2003)].
Amyloid-type fibers PrPSc will be formed, if in the absence of membrane
prion sequence [Saez-Cirion et al. (2003)].
– Tcherkasskaya et al. (2003) reported that hydrophobic interactions be-
tween side chains of the peptide variants PrP(104–122) (containing a po-
lar head KTNMKN followed by a long hydrophobic tail MAGAAAAA-
GAVV) and PrP(109–122) prevent the formation of the rigid β-sheet struc-
tures [Tcherkasskaya et al. (2003)].
– Premzl et al. (2003) reported that the alignment of the hydrophobic seg-
ment shows strong conservation across all PrPs and Shadoos; 12 of the 20
residues of the hydrophobic region are identical or almost identical, and
another 6 are conserved hydrophobic [Premzl et al. (2003)].
– Cui et al. (2003) investigated the deletions of the hydrophobic domain
(PrP∆(112-119), PrP(112-136), PrP(135-150)) and found that the conserved
hydrophobic core region is a critical domain for the activity of PrP [Cui et al.
(2003)].
– Kourie et al. (2003) reported that copper modulates the ion channels of
PrP[106–126] mutant prion peptide fragments, the hydrophobic core AGAAAAGA
is not a ligand Cu(2+) site but the Cu(2+)-binding site is located at M(109)
and H(111) of prion fragment PrP[106–126] [Kourie et al. (2003)].
– In mouse PrP, the selected rabbit-specific mutations Asn99Gly, Leu108Met,
Asn173Ser, and Val214Ile significantly interfere with the conversion of
PrPC to PrPSc [Vorberg et al. (2003)].
• 2002:
– Suzuki et al. (2002) reported that Fugu PrP-like has the PrP-conserved hy-
drophobic region of the Xenopus PrP (but doppel gene lacks PrP conserved
hydrophobic region) [Suzuki et al. (2002)].
– The amino acid sequence AGAAAAGA, comprising residues 112-119 of
the murine PrPC, has been shown to be amyloidogenic and evolutionar-
ily conserved [Zhang (2014b)]. To assess the effect of mutations at and
around this hydrophobic sequence on protease resistance, Wegner et al.
(2002) replaced the sequence either by alanines or by glycines and, in a
third mutant, a large part surrounding this region was removed. At last
Wegner et al. (2002) concluded that “mutations in the central hydropho-
bic region lead to immediate alterations in PrP structure and processing”
[Wegner et al. (2002)].
– Chen et al. (2002) reported “one O-linked sugar at Ser135 can affect
the coil-to-beta structural transition of the prion peptide” but at Ser132
the effect is opposite [Chen et al. (2002)], where PrPC(132-140) domain
is closely related to the prion propagation and 132–140 portion of PrPC is
a logical target for development of anti-prion drugs [Peretz et al. (2001)].
• 2001:
– Dragani et al. (2001) showed that, in the hydrophobic core of all GST
(glutathione S-transferase) and related protein (including the yeast prion
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protein Ure2), at the beginning of α6-helix of GST domain II, a N-capping
box (S/TxxD) and an hydrophobic staple motif are strictly conserved in all
GSTs and GST-related proteins [Dragani et al. (2001); Khan et al. (2010);
Sweeting et al. (2013)].
– Holscher et al. (2001) reported that “deletion of each of the two hydropho-
bic regions in PrP (i.e. ∆PrP(112–121), ∆PrP(231-254)) revealed that the
C-terminally located hydrophobic region (transmembrane2, PrP(213–254))
can function as second signal sequence in PrP” [Holscher et al. (2001)].
– A direct correlation between the PrP amino acid sequence and TSE incuba-
tion time was demonstrated in transgenic mice expressing mouse PrP with
amino acid substitutions Val111Met, Leu108Met, Pro101Leu [Supattapone et al.
(2001); Barron et al. (2001, 2003)].
– Knaus et al. (2001) observed the N-terminal residues PrP(119-124) in the
electron density of the crystal structure of HuPrP dimer (but the PrP(119–
124) region is disordered in the NMR structure of PrP monomers) [Knaus et al.
(2001)].
– Laws et al. (2001) reported the solid-state NMR structure of MoPrP(89-
143, P101L) [Laws et al. (2001)].
• 1999:
– Ragg et al. (1999) obtained the two-dimensional 1H NMR structure of
PrP(106–126) under the following solvent conditions: deionized water/2,2,2-
trifluoroethanol 50:50 (v/v) and dimethylsulfoxide; and the data were ana-
lyzed by restrained MD calculations [Ragg et al. (1999)]. “In deionized
water at pH 3.5, the peptide adopted a helical conformation in the hy-
drophobic region spanning residues Met112–Leu125, with the most popu-
lated helical region corresponding to the Ala115–Ala119 segment (≈ 10%).
In trifluoroethanol/H2O, the α-helix increased in population especially in
the Gly119–Val122 tract (≈ 25%). The conformation of this region was
found to be remarkably sensitive to pH, as the Ala120–Gly124 tract shifted
to an extended conformation at pH 7. In dimethylsulfoxide, the hydropho-
bic cluster adopted a prevalently extended conformation. For all tested sol-
vents the region spanning residues Asn108–Met112 was present in a ‘turn-
like’ conformation and included His111, situated just before the starting
point of the α-helix. Rather than by conformational changes, the effect of
His111 is exerted by changes in its hydrophobicity, triggering aggregation.
The amphiphilic properties and the pH-dependent ionizable side-chain of
His111 may thus be important for the modulation of the conformational
mobility and heterogeneity of PrP(106–126)” [Ragg et al. (1999)].
– Kanyo et al. (1999) determined the X-ray crystallographic atomic-resolution
structures of Syrian hamster PrP(104–113) binding Fab 3F4 [Kanyo et al.
(1999)]. “The peptide binds in a U-shaped groove on the Fab surface,
with the two specificity determinants, Met109 and Met112, penetrating
deeply into separate hydrophobic cavities formed by the heavy and light
chain complementarity-determining regions, and two intrapeptide hydro-
gen bonds are observed” [Kanyo et al. (1999)].
– Liu et al. (1999) reported some NMR information for the Syrian hamster
PrP(90–123): “the N-terminus (residues 90–119) is largely unstructured
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despite some sparse and weak medium-range NOEs implying the existence
of bends or turns. The transition region between the core domain and flex-
ible N-terminus, i.e., residues 113–128, consists of hydrophobic residues
or glycines and does not adopt any regular secondary structure in aqueous
solution. There are about 30 medium- and long-range NOEs within this hy-
drophobic cluster, so it clearly manifests structure” in 1B10.pdb [Liu et al.
(1999)].
• 1997:
– Smith et al. (1997) compared CD (circular dichroism) data from two pep-
tides corresponding to the hydrophobic region PrP(106–136) which con-
tained either methionine or valine at position 129 and concluded that “there
was no detectable difference between the CD spectra of these peptides ir-
respective of the solvent conditions we used” [Smith et al. (1997)].
• 1996:
– Inouye et al. (1996) revealed the hydrophobic core in prion by X-ray
diffraction as the beta-silk structure [Inouye et al. (1996)].
• 1995:
– Priola et al. (1995) found that “a single hamster PrP amino acid Met138
blocks conversion to protease-resistant PrP in scrapie-infected mouse neu-
roblastoma cells” (while a mouse specific isoleucine Ile138 facilitated the
conversion of mouse PrPC into PrPSc) [Priola et al. (1995)]. They also
found homology at PrP(112–138) was required for mouse PrPC → PrPSc
conversion [Priola et al. (1995); Moore et al. (2005)].
• 1994:
– De Fea et al. (1994) reported that “a charged, extracytoplasmic region,
termed the Stop Transfer Effector (STE) sequence, has been shown to
direct then ascent translocating chain to stop at the adjoining hydropho-
bic domain to generate the first membrane-spanning hydrophobic region
PrP(112–143)” [De Fea et al. (1994)].
• 1993:
– Harris et al. (1993) proposed that the cleavage is lying within a region of
24 amino acids that is identical in chicken PrP and mammalian PrP and is
representing a major processing event that may have physiological as well
as pathological significance [Harris et al. (1993)].
• 1992:
– Muramoto et al. (1992) found that ∆PrP(95–107), ∆PrP(108–121), and
∆PrP(122–140) inhibit the PrPC →PrPSc conversion [Muramoto et al. (1992)].
Kuwata et al. (2003) furthermore reduced the region of residues and found
that mouse PrP(106–126) can form amyloid-like fibrils (“the fibrils contain
≈ 50% β-sheet structure, and strong amide exchange protection is limited
to the central portion of the peptide spanning the palindromic sequence VA-
GAAAAGAV”) [Kuwata et al. (2003)]. PrP(90–140) might be the region
of interactions between PrPC and PrPSc [Viles et al. (2001)].
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• 1987:
– Liao et al. (1987) cloned and sequenced rat prion-related protein (PrP)
cDNA, and showed a 23 amino acids hydrophilic region that extends to
amino acid position 122, and the numerous G-G-G-X repeats, where X is a
hydrophobic amino acid, may function in β-pleated sheet amyloid forma-
tion [Liao et al. (1987)].
– Bazan et al. (1987) analyzed the primary PrP sequence hydrophobicities to
detect potential amphipathic regions and several hydrophobic segments, a
proline- and glycine-rich repeat region and putative glycosylation sites are
incorporated into a PrP model [Bazan et al. (1987)].
Throughout the above review on the recent research advances of PrP hydrophobic re-
gion, we noticed that hydrophobic region PrP(109-136) controls the formation of dis-
eased prions PrPSc conformationally changed from PrPC. Thus, it is necessary to do
MD studies of the PrP(110–136) hydrophobic region in the next section.
3. MD (molecular dynamics) studies on PrP hydrophobic region 110–136
The NMR structure of HuPrP(110-136) in dodecylphosphocholine micelles was
known (2LBG.pdb). We did the MD simulations for this PDB template in [Zhang et al.
(2013)] but we have not published any figure of our MD results. This section will illu-
minate our MD results and their discussions with numerous figures.
The 5 ns’ MD simulations passed (1) successful optimizations of the NMR structure
and its 17 mutants (G114V, A117V, G119A, G119L, G119P, A120P, G123A, G123P,
G124A, L125A, G126A, G127A, G127L, M129V, G131A, G131L, G131P), (2) the
longer enough equilibration phase: the PRESS, VOLUME (DENSITY) and RMSD
(Figs. 1–18) were sufficiently stable, and (3) the successful production phase (Figs.
1–18). In Figs. 1–18, H is the α-helix, B is the residue in isolated β-bridge, E is the
extended strand, G is the 3-helix or 310 helix, I is the pi-helix, T is the hydrogen bonded
turn, S is the bend, and the dashed lines denote hydrogen bonds (HBs).
We found three main HBs GLY/ALA/LEU/PRO131–SER135–ARG136, TYR128–
SER132 have high occupied rates in the N-terminal of PrP structural region; this shows
that PrP(110–124) region of PrP(110–136) (2LBG.pdb) is very unstable. We also found
that there is a salt bridge (SB) between HIS111–LYS110 with the occupied rate 100%
for 13 models. Specially for the mutants G127L, M129V, G131A, and G131L, there
is another SB between HIS111–136ARG linking the head and the tail of HuPrP(110–
136). Seeing the snapshots of 3 ns, 4 ns and 5 ns of mutant G127L in Fig. 13, 4 ns and
5 ns of mutant M129V in Fig. 15, 3 ns, 4 ns and 5 ns of mutant G131A in Fig. 16, and 3
ns, 4 ns and 5 ns of mutant G131L in Fig. 17, we may know the SB HIS111–ARG136
makes these snapshots looking like a “hairpin”. The residue HIS111 is an important
residue in PrP(110–136). Along with the unfolding of α-helical structure of all these 13
models, we found many hydrophobic packings (HPs) disappeared except for some fun-
damental ones MET134–ALA133, LEU130–129MET, VAL122–VAL121–ALA120,
ALA118–ALA117–ALA116–ALA115, and ALA113–MET112 with the occupied rate
100%, where ALA118–ALA117–ALA116–ALA115 are in the core of the palindrome
AGAAAAGA and this might imply to us the hydrophobic core is very hard to break
and this palindrome really has enormous potential to be amyloid fibrils.
11
4. Conclusion
It was reported that PrP hydrophobic region controls the formation into diseased
prions. This article firstly reviewed on the recent research advancements of PrP hy-
drophobic region. Secondly, this article gave explanations on the PrP hydrophobic
region in view of protein three-dimensional (3D) structures and their structural dynam-
ics by numerous figures that illuminated the variations of protein 3D structures, protein
secondary structures, and the snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the
MD simulations. The structural bioinformatics presented in this article can be used as
a reference in 3D images for laboratory experimental works to study PrP hydrophobic
region.
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Figure 1: HuPrP(110-136) Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
HuPrP(110-136).
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Figure 2: Mutant G114V Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G114V.
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Figure 3: Mutant A117V Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant A117V.
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Figure 4: Mutant G119A Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G119A.
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Figure 5: Mutant G119L Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G119L.
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Figure 6: Mutant G119P Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G119P.
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Figure 7: Mutant A120P Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant A120P.
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Figure 8: Mutant G123A Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G123A.
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Figure 9: Mutant G123P Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G123P.
27
Figure 10: Mutant G124A Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G124A.
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Figure 11: Mutant L125A Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant L125A.
29
Figure 12: Mutant G126A Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G126A.
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Figure 13: Mutant G127A Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G127A.
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Figure 14: Mutant G127L Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G127L.
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Figure 15: Mutant M129V Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant M129V.
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Figure 16: Mutant G131A Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G131A.
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Figure 17: Mutant G131L Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G131L.
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Figure 18: Mutant G131P Variations of (A) the root-mean-squared deviations (RMSD), (B) the secondary
structures, and (C) the respective snapshots at 0 ns, 1 ns, 2 ns, 3 ns, 4 ns and 5 ns of the MD simulations for
mutant G131P.
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